Abstract
Aim
Pruritus is common among patients with end-stage renal disease undergoing dialysis, and the pathogenesis can be explained by several mechanisms. However, there is no definite evidence supporting them, which limits the relative efficacy of any individual treatment option. In this paper, we aimed to compare pregabalin with ondansetron in treatment of uraemic pruritus (UP) in dialysis patients.
Methods
In this 12-week prospective, randomized, and double-blind trial, we assessed the efficacy and side effects in UP patients undergoing dialysis. Patients were randomly assigned to receive 12 weeks of 75 mg twice-weekly pregabalin or 8 mg/day ondansetron or a placebo. Visits were scheduled at 0, 2, 4, 6, 8, and 12 weeks after treatment. The severity of pruritus was evaluated using Visual Analogue Scale and modified Duo’s VAG Scale. Quality of sleep was evaluated using the Pittsburgh sleep quality index. The effect of UP on health-related quality of life was assessed using the Chinese version of the 12-item short-form (SF-12) general health survey. Baseline laboratory data and demographic characteristics were recorded from patient charts.
Results
Finally, 179 (108 males, 71 females, aged 54.7 ± 11.3 years old) out of the 188 patients completed the 12-week study. Of five patients who stopped pregabalin treatment due to side effects, two patients reported an improvement in nausea and vomiting among those receiving ondansetron. Two patients dropped out for renal transplantation. The 179 patients included 62 cases from the pregabalin group, 60 from the ondansetron group, and 57 from the placebo group. Over the 12 weeks, only pregabalin improved UP significantly. The severity of pruritus was reduced significantly in the pregabalin group compared with the ondansetron and the placebo groups. The final pruritus scores were not different between the ondansetron and the placebo groups. Pruritus absolutely disappeared in two patients following renal transplantation.
Conclusions
Pregabalin is an effective alternative for treatment of uraemic pruritus. Ondansetron has negligible effect on uremic pruritus and is expensive. A larger sample size may be needed to demonstrate the effect of ondansetron in uraemic pruritus.
Similar content being viewed by others
References
Balaskas EV, Bamihas GI, Karamouzis M et al (1998) Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients. Nephron 78:395–402
Wikstrom B (2007) Itchy skin—a clinical problem for haemodialysis patients. Nephrol Dial Transplant 22(Suppl 5):v3–v7
Mettang M, Weisshaar E (2010) Pruritus: control of itch in patients undergoing dialysis. Skin Ther Lett 15:1–5
Deshpande PV (2004) Ondansetron for paediatric uraemic pruritus: a case report. Pediatr Nephrol 19:694–696
Ashmore SD, Jones CH, Newstead CG et al (2000) Ondansetron therapy for uremic pruritus in hemodialysis patients. Am J Kidney Dis 35:827–831
Weisshaar E, Dunker N, Domrose U et al (2003) Plasma serotonin and histamine levels in hemodialysis-related pruritus are not significantly influenced by 5-HT3 receptor blocker and antihistaminic therapy. Clin Nephrol 59:124–129
To TH, Clark K, Lam L et al (2012) The role of ondansetron in the management of cholestatic or uremic pruritus—a systematic review. J Pain Symptom Manage 44:725–730
Murphy M, Reaich D, Pai P et al (2003) A randomized, placebo-controlled, double-blind trial of ondansetron in renal itch. Br J Dermatol 148:314–317
Fusaro M, Munaretto G, Spinello M et al (2004) Regression of uraemic pruritus by cyclosporin treatment in a haemodialysis patient. Nephrol Dial Transplant 19:1338–1339
Kuypers DR, Claes K, Evenepoel P et al (2004) A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy. Nephrol Dial Transplant 19:1895–1901
Inui S (2012) Nalfurafine hydrochloride for the treatment of pruritus. Expert Opin Pharmacother 13:1507–1513
Ko MJ, Yang JY, Wu HY et al (2011) Narrowband ultraviolet B phototherapy for patients with refractory uraemic pruritus: a randomized controlled trial. Br J Dermatol 165:633–639
Avermaete A, Altmeyer P, Bacharach-Buhles M (2002) Skin changes and tumours after renal transplantation. Nephron 91:188–194 (discussion 194–196)
Makari J, Cameron K, Battistella M (2013) Understanding pruritus in dialysis patients. CANNT J 23:19–23 (quiz 24–25)
Mettang T, Kremer AE (2014) Uremic pruritus. Kidney Inter Adv Online Pub. doi:10.1038/ki.2013.454
Szepietowski JC, Balaskas E, Taube KM et al (2011) Quality of life in patients with uraemic xerosis and pruritus. Acta Derm Venereol 91:313–317
Rayner H, Baharani J, Smith S et al (2012) Uraemic pruritus: relief of itching by gabapentin and pregabalin. Nephron Clin Pract 122:75–79
Solak Y, Biyik Z, Atalay H et al (2012) Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study. Nephrology (Carlton) 17:710–717
Mettang T, Fritz P, Weber J et al (1990) Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). The role of plasma histamine and skin mast cells. Clin Nephrol 34:136–141
Zhang J, Huang C, Li Y et al (2013) Health-related quality of life in dialysis patients with constipation: a cross-sectional study. Patient Prefer Adherence 7:589–594
Rebollo P, Ortega F, Baltar JM et al (2000) Health related quality of life (HRQOL) of kidney transplanted patients: variables that influence it. Clin Transplant 14:199–207
Mathur VS, Lindberg J, Germain M et al (2010) A longitudinal study of uremic pruritus in hemodialysis patients. Clin J Am Soc Nephrol 5:1410–1419
Gonella M, Calabrese G, Mazzotta A et al (2007) Uraemic pruritus in RDT patients: is it still a problem. Nephrol Dial Transplant 22:3669
Susel J, Batycka-Baran A, Reich A et al (2014) Uraemic pruritus markedly affects the quality of life and depressive symptoms in haemodialysis patients with end-stage renal disease. Acta Derm Venereol 94:276–281
Manenti L, Tansinda P, Vaglio A (2009) Uraemic pruritus: clinical characteristics, pathophysiology and treatment. Drugs 69:251–263
Dashti-Khavidaki S, Khalili H, Vahedi SM et al (2010) Serum zinc concentrations in patients on maintenance hemodialysis and its relationship with anemia, parathyroid hormone concentrations and pruritus severity. Saudi J Kidney Dis Transplant 21:641–645
Stolic R, Trajkovic G, Peric V et al (2007) Parametres of clinical and biohumoral status of pruritus in patients on chronic haemodialysis. Med Pregl 60(Suppl 2):101–103
Kimmel M, Alscher DM, Dunst R et al (2006) The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients. Nephrol Dial Transplant 21:749–755
Gatmiri SM, Mahdavi-Mazdeh M, Lessan-Pezeshki M et al (2013) Uremic pruritus and serum phosphorus level. Acta Med Iran 51:477–481
Pisoni RL, Wikstrom B, Elder SJ et al (2006) Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 21:3495–3505
Ahuja RB, Gupta GK (2013) A four arm, double blind, randomized and placebo controlled study of pregabalin in the management of post-burn pruritus. Burns 39:24–29
Shavit L, Grenader T, Lifschitz M et al (2013) Use of pregabalin in the management of chronic uremic pruritus. J Pain Symptom Manage 45:776–781
Park JM, Jwa SW, Song M et al (2012) Efficacy and safety of pregabalin for the treatment of chronic pruritus in Korea. J Dermatol 39:790–791
Kim K (2012) Neuroimmunological mechanism of pruritus in atopic dermatitis focused on the role of serotonin. Biomol Ther (Seoul) 20:506–512
Conflict of interest
The authors report no conflicts of interest. The authors alone were responsible for the content and writing of the paper.
Author information
Authors and Affiliations
Corresponding author
Additional information
Ji Yue, Shoufeng Jiao, Yangfei Xiao and Wei Ren have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Yue, J., Jiao, S., Xiao, Y. et al. Comparison of pregabalin with ondansetron in treatment of uraemic pruritus in dialysis patients: a prospective, randomized, double-blind study. Int Urol Nephrol 47, 161–167 (2015). https://doi.org/10.1007/s11255-014-0795-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-014-0795-x